Stanford Medicine Corporate Partners
The impact of the Corporate Partners program will be profound. Stanford Health Care, Lucile Packard Children’s Hospital Stanford and the Stanford School of Medicine are joining with the pioneering leaders of Silicon Valley to deliver a new standard of proactive, predictive medicine to patients of all ages.
David Entwistle
President and CEO of Stanford Health Care
Established in 2011, the Stanford Medicine Corporate Partners is a philanthropic engagement between Stanford Medicine and leading global companies to inspire and create solutions to improve patient care and promote lifelong health on a global scale.
Stanford Medicine Corporate Partners include Adobe, Apple, Cisco, eBay, HP, Hewlett Packard Enterprise, Intel, Intuit, NVIDIA, Oracle, Paypal, and VMware.
Together, we are transforming the very concept of medicine—from preventing and predicting disease, successfully treating it after it has struck, and promoting lifelong health.
For more information about Stanford Medicine Corporate Partners:
Visit the website or email cpnavigators@stanfordhealthcare.org
Dan Polcyn
Executive Director Corporate Health Services
Stanford Health Care
dpolcyn@stanfordhealthcare.org
Corporate Relations
In addition to the Stanford Medicine Corporate Partners Program, there are a number of ways in which companies can leverage their resources through a relationship with Stanford Medicine.
Support faculty, students, or facilities through a broad partnership
By making gifts to Stanford Medicine, corporations strengthen their relationship with one of the world's leading research universities, support departments and faculty engaged in research related to their interests, honor individuals who have played key roles in their success, introduce their companies and their products to future users, and support and encourage the philanthropy of their employees. For more information, contact Joy Morimoto, Director of Corporate and Foundation Relations, at 650.736.9749 or joym@stanford.edu.
License specific technology
Stanford's licensing activities involve inventions, patents, biological materials, software, equipment, and copyrightable materials. By working closely with inventors and industry, Stanford seeks to maximize the value of technology for the future. Technology transfer has become a key concept in national, regional, and global economic development. In the entrepreneurial environment of Silicon Valley, Stanford University and its Office of Technology Licensing (OTL) have become models for successful technology transfer. For more information, contact the Office of Technology Licensing .
Sponsor research
As a major research university, Stanford receives a significant portion of its funding from organizations that sponsor research by financially underwriting projects at Stanford. Usually awarded upon submission and evaluation of a proposal, sponsored projects typically include a statement of work, a budget, and terms for the disposition of resulting tangible and intangible property.
Why might industry contract out their research efforts to a university? The answers are as varied as the intellectual questions behind the projects; however we believe the answer is a desire to make the best use of limited corporate resources, to take advantage of unique research facilities, and to engage faculty and students in questions which will impact the future of the world. For more information, contact the Industrial Contracts Office .
Sponsor clinical trials
Clinical trials are ongoing at Stanford Medicine involving pharmaceutical, biotechnology, and medical device therapeutics. The clinical faculty participate in Phase I, II, and III clinical trials, as well as industry-sponsored preclinical research and human subjects studies for new indications for approved drugs (Phase IV). Many clinical trials are part of a multi-center format, and Stanford has served as the organizing site for some of these trials. For more information, contact:
- Non-cancer studies:
Linda Walker, Program Manager, Spectrum, at lswalker@stanford.edu or 650.498.6498 - For cancer-related trials:
The Cancer Clinical Trials Office (CCTO) at ccto-website@stanford.edu or 650.724.0153.
Support a faculty member's research
Contact us
For more information, please contact:
Joy Morimoto
Director of Corporate and Foundation Relations
Medical Center Development
650.736.9749
joym@stanford.edu
Deborah Lin
Senior Associate Director
Corporate, Foundation, and Association Relations
Medical Center Development
650.507.5270
debllin@stanford.edu